SEMIOSICA
Significazione Medica
SEMIOSICA
Significazione Medica
INFORMAZIONI LEGALI
INFORMAZIONI PER GLI UTENTI
SEMIOSICA SRL
Forma giuridica: SRL unipersonale.
Capitale sociale: euro 10.000 int. vers.
Sede legale: Piazza Libertà 34, 36061, Bassano del Grappa, Vicenza, Italia.
Codice fiscale / Partita IVA: 04505690240.
SEMIOSICA
Posta elettronica: info@semiosica.com.
Privacy Policy:
Cookie Policy:
Sito web: www.semiosica.com
LA SIGNIFICAZIONE MEDICA
PER LA MEDICINA MOTORIA
Note bibliografiche
1. Il medico radiologo. Manuale di legislazione, management e deontologia. di Corrado Bibbolino, Antonio Pinto, Bruno Accarino, Paolo Sartori, Antonio Orlacchio. 25 febbraio 2021.
2. https://www.sirm.org/wp-content/uploads/2021/04/311-Documento-SIRM-2019-Atto-Medico-Radiologico.pdf
3. CITTADINI Diagnostica per immagini e radioterapia. Giorgio Cittadini, Giuseppe Cittadini, Francesco Sardanelli. Edra editore. 2015
4. Catalano. ECOGRAFIA. Dalle basi metodologiche alle Tecniche Avanzate. Catalano Orlando, Farina Roberto. Eli Medica Editore. Novembre 2017
5. Elementi di risonanza magnetica: Dal Protone Alle Sequenze Per Le Principali Applicazioni Diagnostiche. Mario Coriasco. Springer Editore. 2014
6. Capire la radiologia: le basi della diagnostica per immagini. William Herring, Andrea Giovagnoni. Piccin-Nuova Libraria Editore. 2020
7. Scatliff JH, Morris PJ. From Roentgen to magnetic resonance imaging: the history of medical imaging. N C Med J. 2014 Mar-Apr;75(2):111-3. doi: 10.18043/ncm.75.2.111. PMID: 24663131.
8. Pavlou A, Kurtz RM, Song JW. Diagnostic Accuracy Studies in Radiology: How to Recognize and Address Potential Sources of Bias. Radiol Res Pract. 2021 Sep 6;2021:5801662
9. Emmerson BR, Young M. Radiology Patient Safety and Communication. [Updated 2023 Jan 30]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan.
10. Htay, Mila & Kamath, Ganesh & KM, Anand & Sugathan, Sandheep & Luyee, Eunice & Sahoo, Soumendra. Overview of Reliability and Validity of Assessments in Medical Education. ResearchGate. 2023
11. Pelvic Pain in Women. M. Brigid Holloran-Schwartz MD, in Obstetrics and Gynecology Clinics of North America, 2014
12. Winkler N, Buxton J, Freer P, Raps E, Barraza G, Boucher K, Riegert J, Factor R. Comparison of Diagnostic Sensitivity and Procedure-Related Pain of Concurrent Ultrasound-guided Fine-needle Aspiration and Core-needle Biopsy of Axillary Lymph Nodes in Patients with Suspected or Known Breast Cancer. J Breast Imaging. 2023 Jul 28;5(4):436-444. doi: 10.1093/jbi/wbad031. PMID: 38416904.
13. Compendio di Radiologia Medica. Eugenio Milani, Adamo Grilli. Società Editrice Universo. 1955
14. Expert Panel on Cardiac Imaging; Ghoshhajra BB, Hedgire SS, Hurwitz Koweek LM, Beache GM, Brown RKJ, Davis AM, Hsu JY, Johnson TV, Kicska GA, Kligerman SJ, Litmanovich D, Maroules CD, Meyersohn N, Rabbat MG, Villines TC, Wann S, Abbara S. ACR Appropriateness Criteria® Asymptomatic Patient at Risk for Coronary Artery Disease: 2021 Update. J Am Coll Radiol. 2021 May;18(5S):S2-S12. European Society of Radiology (ESR). ESR communication guidelines for radiologists. Insights Imaging. 2013 Apr;4(2):143-6.
15. Pulumati A, Dwarakanath BS, Verma A, Papineni RVL. Technological advancements in cancer diagnostics: Improvements and limitations. Cancer Rep (Hoboken). 2023 Feb;6(2):e1764. doi: 10.1002/cnr2.1764. Epub 2023 Jan 6. PMID: 36607830; PMCID: PMC9940009.
16. Screening for Preclinical Disease: Test and Disease Characteristics. Cheryl R. Herman, Harmindar K. Gill, John Eng, and Laurie L. Fajardo. American Journal of Roentgenology. October 2002. Volume 179, Issue 4.
17. Iragorri N, Spackman E. Assessing the value of screening tools: reviewing the challenges and opportunities of cost-effectiveness analysis. Public Health Rev. 2018 Jul 13;39:17. doi: 10.1186/s40985-018-0093-8. PMID: 30009081; PMCID: PMC6043991.
18. Breast Cancer Screening for Women at Higher-Than-Average Risk: Updated Recommendations From the ACR. Monticciolo, Debra L. et al. Journal of the American College of Radiology, Volume 20, Issue 9, 902 - 914
19. Zhang YN, Fowler KJ, Hamilton G, Cui JY, Sy EZ, Balanay M, Hooker JC, Szeverenyi N, Sirlin CB. Liver fat imaging-a clinical overview of ultrasound, CT, and MR imaging. Br J Radiol. 2018 Sep;91(1089):20170959. doi: 10.1259/bjr.20170959. Epub 2018 Jun 6. PMID: 29722568; PMCID: PMC6223150.
20. Miranda, J., Key Wakate Teruya, A., Leão Filho, H. et al. Diffuse and focal liver fat: advanced imaging techniques and diagnostic insights. Abdom Radiol (2024)
21. Evidence for avoiding the biopsy of typical fibroadenomas in women aged 25–29 years. Taylor, K. et al.Clinical Radiology, Volume 74, Issue 9, 676 - 681
22. Olliaro P, Torreele E. Managing the risks of making the wrong diagnosis: First, do no harm. Int J Infect Dis. 2021 May;106:382-385. doi: 10.1016/j.ijid.2021.04.004. Epub 2021 Apr 15. PMID: 33845195; PMCID: PMC8752462.
23. Chauhan N. A wrong diagnosis. Indian J Cancer. 2020 Apr-Jun;57(2):212-215. doi: 10.4103/ijc.IJC_418_19. PMID: 32445328.
24. Maxim LD, Niebo R, Utell MJ. Screening tests: a review with examples. Inhal Toxicol. 2014 Nov;26(13):811-28. doi: 10.3109/08958378.2014.955932. Epub 2014 Sep 29. Erratum in: Inhal Toxicol. 2019 Jun;31(7):298. doi: 10.1080/08958378.2019.1674481. PMID: 25264934; PMCID: PMC4389712.
25. Earlier diagnosis: the importance of cancer symptoms. Whitaker, Katriina. The Lancet Oncology, Volume 21, Issue 1, 6 - 8
26. Bollati V, Ferrari L, Leso V, Iavicoli I. Personalised Medicine: implication and perspectives in the field of occupational health. Med Lav. 2020 Nov 25;111(6):425-444. doi: 10.23749/mdl.v111i6.10947. PMID: 33311418; PMCID: PMC7809984.
27. Prevention Strategies. StatPearls [Internet]. Lisa A. Kisling; Joe M. Das. August 1, 2023.
28. Ballard DH, Burton KR, Lakomkin N, Kim S, Rajiah P, Patel MJ, Mazaheri P, Whitman GJ. The Role of Imaging in Health Screening: Screening for Specific Conditions. Acad Radiol. 2021 Apr;28(4):548-563.
29. Oeffinger KC, Fontham ET, Etzioni R, et al. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA. 2015; 314(15): 1599–1614. [PMC free article] [PubMed] [Google Scholar]
30. Linee guida per la produzione di intervalli di riferimento D. Giavarinaa , R. M. Dorizzib , G. Guerrac. Riv Med Lab - JLM, Vol. 2, S.1, 2001
31. Givler DN, Givler A. Health Screening. [Updated 2023 Feb 19]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan
32. Dobrow MJ, Hagens V, Chafe R, Sullivan T, Rabeneck L. Consolidated principles for screening based on a systematic review and consensus process. CMAJ. 2018 Apr 9;190(14):E422-E429.
33. Gaitskell K. Personalised Medicine Approaches to Screening and Prevention. New Bioeth. 2017 Apr;23(1):21-29. doi: 10.1080/20502877.2017.1314884. PMID: 28517984.
34. Filippo Pesapane, Anna Rotili, Sara Raimondi, Gaetano Aurilio, Matteo Lazzeroni, Luca Nicosia, Antuono Latronico, Maria Pizzamiglio, Enrico Cassano, Sara Gandini. Evolving paradigms in breast cancer screening: Balancing efficacy, personalization, and equity. European Journal of Radiology. Volume 172, 2024.
35. Dobrow MJ, Hagens V, Chafe R, Sullivan T, Rabeneck L. Consolidated principles for screening based on a systematic review and consensus process. CMAJ. 2018 Apr 9;190(14):E422-E429.
36. Dillner J. Early detection and prevention. Mol Oncol. 2019 Mar;13(3):591-598. doi: 10.1002/1878-0261.12459. Epub 2019 Feb 27. PMID: 30676688; PMCID: PMC6396346.
37. AbdulRaheem Y. Unveiling the Significance and Challenges of Integrating Prevention Levels in Healthcare Practice. J Prim Care Community Health. 2023 Jan-Dec;14:21501319231186500. doi: 10.1177/21501319231186500. PMID: 37449436; PMCID: PMC10350749.
38. Linda C. Baumann, Alyssa Karel.Prevention: Primary, Secondary, Tertiary. Encyclopedia of Behavioral Medicine, 2013. ISBN : 978-1-4419-1004-2
39. Khattak ZE, El Sharu H, Bhutta BS. Overview on Ordering and Evaluation of Laboratory Tests. [Updated 2023 Aug 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-.
40. Gounden V, Bhatt H, Jialal I. Renal Function Tests. [Updated 2024 Jul 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan.
41. Bhattacharya CG. A simple method of resolution of a distribution into gaussian components. Biometrics 1967;23:115-35.
42. Vidali, M. (2023). The Role of Statistics in Laboratory Medicine. In: Ciaccio, M. (eds) Clinical and Laboratory Medicine Textbook. Springer, Cham. https://doi.org/10.1007/978-3-031-24958-7_4
43. Cohen NM, Schwartzman O, Jaschek R, Lifshitz A, Hoichman M, Balicer R, Shlush LI, Barbash G, Tanay A. Personalized lab test models to quantify disease potentials in healthy individuals. Nat Med. 2021 Sep;27(9):1582-1591. doi: 10.1038/s41591-021-01468-6. Epub 2021 Aug 23. PMID: 34426707.
44. Whyte, M. B. & Kelly, P. The normal range: it is not normal and it is not a range. Postgrad. Med. J. 94, 613–616 (2018). - DOI
45. Variabilità biologica dei parametri ematologici M. Buttarello. Riv Med Lab - JLM, Vol. 4, S.1, 2003
46. Maxim LD, Niebo R, Utell MJ. Screening tests: a review with examples. Inhal Toxicol. 2014 Nov;26(13):811-28. doi: 10.3109/08958378.2014.955932. Epub 2014 Sep 29. Erratum in: Inhal Toxicol. 2019 Jun;31(7):298. doi: 10.1080/08958378.2019.1674481. PMID: 25264934; PMCID: PMC4389712.
47. Costongs GMPJ, Janson PCW, Bas BM, Hermans J, Brombacher PJ, Van Wersch JWJ. Short-term and long-term intraindividual variations and critical difference of haematological laboratory parameters. J Clin Chem Clin Biochem 1985; 23:69-76.
48. Cotlove E, Harris EK, Williams GZ. Components of variation in long-term studies of serum constituents in normal subjects. III. Phisiological and medical implications. Clin Chem 1970; 16: 1028-32
49. Il “referto” in Medicina di Laboratorio Piero Cappelletti. Riv Med Lab - JLM, Vol. 5, N. 3, 200.
50. Lundberg GD. Acting on significant laboratory results. JAMA 1981;245:1763 24.
51. Aller RD. Interpretive reporting. Clin lab med 1983;3:205-17
52. Wilson CH. The Musculoskeletal Examination. In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd ed. Butterworths; Boston: 1990.
53. Ömerhoca S, Akkaş SY, İçen NK. Multiple Sclerosis: Diagnosis and Differential Diagnosis. Noro Psikiyatr Ars. 2018;55(Suppl 1):S1-S9. doi: 10.29399/npa.23418. PMID: 30692847; PMCID: PMC6278620.
54. Tests for diagnosing and monitoring non-alcoholic fatty liver disease in adults. BMJ 2018; 362
55. Qaja E, Tadi P, Theetha Kariyanna P. Symptomatic Carotid Artery Stenosis.StatPearls. 2024 Jan
56. Sharma S. Tumor markers in clinical practice: General principles and guidelines. Indian J Med Paediatr Oncol. 2009 Jan;30(1):1-8
57. Bhatt AN, Mathur R, Farooque A, Verma A, Dwarakanath BS. Cancer biomarkers - current perspectives. Indian J Med Res. 2010 Aug;132:129-49
58. Khattak ZE, El Sharu H, Bhutta BS. Overview on Ordering and Evaluation of Laboratory Tests. [Updated 2023 Aug 17]. StatPearls Publishing; 2024 Jan.
59. Ballard DH, Burton KR, Lakomkin N, Kim S, Rajiah P, Patel MJ, Mazaheri P, Whitman GJ. The Role of Imaging in Health Screening: Screening for Specific Conditions. Acad Radiol. 2021 Apr;28(4):548-563. doi: 10.1016/j.acra.2020.03.039. Epub 2020 May 11. PMID: 32404272; PMCID: PMC7655640.
60. Sopcak N, Fernandes C, O'Brien MA, Ofosu D, Wong M, Wong T, Kebbe M, Manca D. What is a prevention visit? A qualitative study of a structured approach to prevention and screening - the BETTER WISE project. BMC Fam Pract. 2021 Jul 19;22(1):153. doi: 10.1186/s12875-021-01503-y. PMID: 34275453; PMCID: PMC8287802.
61. Kisling LA, Das JM. Prevention Strategies. [Updated 2023 Aug 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan
62. Fowler T, Garr D, Mager NDP, Stanley J. Enhancing primary care and preventive services through Interprofessional practice and education. Isr J Health Policy Res. 2020 Mar 23;9(1):12. doi: 10.1186/s13584-020-00371-8. PMID: 32204734; PMCID: PMC7092466.
63. Golubnitschaja O, Kinkorova J, Costigliola V. Predictive, Preventive and Personalised Medicine as the hardcore of 'Horizon 2020': EPMA position paper. EPMA J. 2014 Apr 7;5(1):6.
64. Golubnitschaja O, Watson ID, Topic E, Sandberg S, Ferrari M, Costigliola V. Position paper of the EPMA and EFLM: a global vision of the consolidated promotion of an integrative medical approach to advance health care. EPMA J. 2013 May 10;4(1):12. doi: 10.1186/1878-5085-4-12. PMID: 23663422; PMCID: PMC3700840.
65. Hutchison BG, Abelson J, Woodward CA, Norman G. Preventive care and barriers to effective prevention. How do family physicians see it? Can Fam Physician. 1996 Sep;42:1693-700. PMID: 8828872; PMCID: PMC2146897.
66. AbdulRaheem Y. Unveiling the Significance and Challenges of Integrating Prevention Levels in Healthcare Practice. Journal of Primary Care & Community Health. 2023;14
67. Fowler T, Garr D, Mager NDP, Stanley J. Enhancing primary care and preventive services through Interprofessional practice and education. Isr J Health Policy Res. 2020;9(1):12.
68. Ali A, Katz DL. Disease prevention and health promotion: how integrative medicine fits. Am J Prev Med. 2015;49(5 Suppl 3):S230-S240.
69. Atiana Z, Allan JD, Mary BB, et al. The roles of healthcare professionals in implementing clinical prevention and population health. Am J Prevent Med. 2011;40(2):261-267.
70. Baumann LC, Ylinen A. Prevention: primary, secondary, tertiary. In: Gellman MD, ed. Encyclopedia of behavioral medicine. Springer. 2020: 1738–1740.
71. Jerant AF. Clinical prevention. In: Taylor RB, David AK, Fields SA, Phillips DM, Scherger JE, eds. Fundamentals of Family Medicine. Springer; 2003: 19-56.
72. Maxim LD, Niebo R, Utell MJ. Screening tests: a review with examples. Inhal Toxicol. 2014 Nov;26(13):811-28. doi: 10.3109/08958378.2014.955932. Epub 2014 Sep 29. Erratum in: Inhal Toxicol. 2019 Jun;31(7):298. doi: 10.1080/08958378.2019.1674481. PMID: 25264934; PMCID: PMC4389712.
73. Spak DA, Plaxco JS, Santiago L, Dryden MJ, Dogan BE. BI-RADS® fifth edition: A summary of changes. Diagn Interv Imaging. 2017;98(3):179–190. [PubMed] [Google Scholar]
74. 2. Martin MD, Kanne JP, Broderick LS, Kazerooni EA, Meyer CA. Lung-RADS: Pushing the limits. Radiographics. 2017;37(7):1975–1993. [PubMed] [Google Scholar]
75. 3. Kim DH, Moreno CC, Pickhardt PJ. Computed tomography colonography: Pearls and pitfalls. Radiol Clin North Am. 2018;56(5):719–735. [PubMed] [Google Scholar]
76. 4. Sprynger M, Willems M, Van Damme H, Drieghe B, Wautrecht JC, Moonen M. Screening program of abdominal aortic aneurysm. Angiology. 2019;70(5):407–413. [PubMed] [Google Scholar]
77. 5. Schroder AGD, de Araujo CM, Guariza-Filho O, Flores-Mir C, de Luca Canto G, Porporatti AL. Diagnostic accuracy of panoramic radiography in the detection of calcified carotid artery atheroma: a meta-analysis. Clin Oral Investig. 2019;23(5):2021–2040. [PubMed] [Google Scholar]
78. Lee CH, Dershaw DD, Kopans D, et al. Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. JACR. 2010; 7(1): 18–27. [PubMed] [Google Scholar]
79. Karanjia RN, Crossey MM, Cox IJ, Fye HK, Njie R, Goldin RD, Taylor-Robinson SD. Hepatic steatosis and fibrosis: Non-invasive assessment. World J Gastroenterol. 2016 Dec 7;22(45):9880-9897. doi: 10.3748/wjg.v22.i45.9880. PMID: 28018096; PMCID: PMC5143756.
80. Cabalar I, Le TH, Silber A, O'Hara M, Abdallah B, Parikh M, Busch R. The role of blood testing in prevention, diagnosis, and management of chronic diseases: A review. Am J Med Sci. 2024 Oct;368(4):274-286. doi: 10.1016/j.amjms.2024.04.009. Epub 2024 Apr 16. PMID: 38636653.
81. Ebert N, Bevc S, Bökenkamp A, Gaillard F, Hornum M, Jager KJ, Mariat C, Eriksen BO, Palsson R, Rule AD, van Londen M, White C, Schaeffner E. Assessment of kidney function: clinical indications for measured GFR. Clin Kidney J. 2021 Feb 22;14(8):1861-1870
82. European Institute for Biomedical Imaging Research (EIBIR). Strategic research agenda for biomedical imaging. Insights Imaging. 2019 Jan 28;10(1):7. doi: 10.1186/s13244-019-0684-z. PMID: 30693378; PMCID: PMC6352390.
83. Soares CO, Pereira BF, Pereira Gomes MV, Marcondes LP, de Campos Gomes F, de Melo-Neto JS. Preventive factors against work-related musculoskeletal disorders: narrative review. Rev Bras Med Trab. 2020 Apr 15;17(3):415-430. doi: 10.5327/Z1679443520190360. PMID: 32368676; PMCID: PMC7195879.
84. Inzitari D. The Italian Guidelines for stroke prevention. The Stroke Prevention and Educational Awareness Diffusion (SPREAD) Collaboration. Neurol Sci. 2000 Feb;21(1):5-12. doi: 10.1007/s100720070112. PMID: 10938196.
85. Institute of Medicine (US) and National Research Council (US) National Cancer Policy Board; Curry SJ, Byers T, Hewitt M, editors. Fulfilling the Potential of Cancer Prevention and Early Detection. Washington (DC): National Academies Press (US); 2003. 5, Potential of Screening to Reduce the Burden of Cancer. Available from:
86. MRI of the Aortic Wall to Assess Cardiovascular Risk and Prognosis. Ronald M. Peshock. Radiology 2022 304:3, 551-552
87. Raptis AE, Markakis KP, Mazioti MC, Raptis SA, Dimitriadis GD. What the radiologist needs to know about the diabetic patient. Insights Imaging. 2011 Apr;2(2):193-203. doi: 10.1007/s13244-011-0068-5. Epub 2011 Feb 2. PMID: 22347947; PMCID: PMC3259362.
88. Stephenson SD, Kocan JW, Vinod AV, Kluczynski MA, Bisson LJ. A Comprehensive Summary of Systematic Reviews on Sports Injury Prevention Strategies. Orthop J Sports Med. 2021 Oct 28;9(10):23259671211035776. doi: 10.1177/23259671211035776. PMID: 34734094; PMCID: PMC8558815.
89. Kohyama J, Fujitani S, Umesato Y, Kataoka H. Disease staging as a measure of disease severity. J Med Dent Sci. 2015 Jun 24;62(2):25-32. doi: 10.11480/620201. PMID: 26183830.
90. Rodriguez-Araujo G, Nakagami H. Pathophysiology of cardiovascular disease in diabetes mellitus. Cardiovasc Endocrinol Metab. 2018 Feb 14;7(1):4-9. doi: 10.1097/XCE.0000000000000141. PMID: 31646271; PMCID: PMC6739883.
91. Lifestyle Modification for Diabetes and Heart Disease Prevention. Richa Patel; Reddog E. Sina; Daniel Keyes. Author Information and Affiliations. Last Update: February 12, 2024.
92. Airhihenbuwa CO, Tseng TS, Sutton VD, Price L. Global Perspectives on Improving Chronic Disease Prevention and Management in Diverse Settings. Prev Chronic Dis. 2021 Apr 8;18:E33. doi: 10.5888/pcd18.210055. PMID: 33830913; PMCID: PMC8051856.
93. Rebecca L. Siegel et al., Colorectal Cancer in the Young: Epidemiology, Prevention, Management. Am Soc Clin Oncol Educ Book 40, e75-e88(2020).
94. Pigeot I, De Henauw S, Foraita R, Jahn I, Ahrens W. Primary prevention from the epidemiology perspective: three examples from the practice. BMC Med Res Methodol. 2010 Feb 3;10:10. doi: 10.1186/1471-2288-10-10. PMID: 20128907; PMCID: PMC2829018.
95. Razzak MI, Imran M, Xu G. Big data analytics for preventive medicine. Neural Comput Appl. 2020;32(9):4417-4451. doi: 10.1007/s00521-019-04095-y. Epub 2019 Mar 16. PMID: 32205918; PMCID: PMC7088441.
96. Winn AN, Ekwueme DU, Guy GP Jr, Neumann PJ. Cost-Utility Analysis of Cancer Prevention, Treatment, and Control: A Systematic Review. Am J Prev Med. 2016 Feb;50(2):241-8. doi: 10.1016/j.amepre.2015.08.009. Epub 2015 Oct 23. PMID: 26470806; PMCID: PMC5846573.
97. Lam DL, Pandharipande PV, Lee JM, Lehman CD, Lee CI. Imaging-based screening: understanding the controversies. AJR Am J Roentgenol. 2014 Nov;203(5):952-6. doi: 10.2214/AJR.14.13049. PMID: 25341132; PMCID: PMC4220242.
98. Jennings C, Astin F. A multidisciplinary approach to prevention. Eur J Prev Cardiol. 2017 Jun;24(3_suppl):77-87. doi: 10.1177/2047487317709118. PMID: 28618913.
99. Levine S, Malone E, Lekiachvile A, Briss, P. Health care industry insights: why the use of preventive services is still low. 2019. https://www.cdc.gov/pcd/issues/2019/18_0625.htm.
100. Lewis R, Gómez Álvarez CB, Rayman M, Lanham-New S, Woolf A, Mobasheri A. Strategies for optimising musculoskeletal health in the 21st century. BMC Musculoskelet Disord. 2019 Apr 11;20(1):164.
101. Dalise S, Azzollini V, Chisari C. Brain and Muscle: How Central Nervous System Disorders Can Modify the Skeletal Muscle. Diagnostics (Basel). 2020 Dec 4;10(12):1047. doi: 10.3390/diagnostics10121047. PMID: 33291835; PMCID: PMC7762031.
102. Pulumati A, Pulumati A, Dwarakanath BS, Verma A, Papineni RVL. Technological advancements in cancer diagnostics: Improvements and limitations. Cancer Rep (Hoboken). 2023 Feb;6(2):e1764.
103. Gimnich, O.A., Zil-E-Ali, A. & Brunner, G. Imaging Approaches to the Diagnosis of Vascular Diseases. Curr Atheroscler Rep 24, 85–96 (2022). https://doi.org/10.1007/s11883-022-00988-x
104. Tamaki N, Ajmera V, Loomba R. Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD. Nat Rev Endocrinol. 2022 Jan;18(1):55-66. doi: 10.1038/s41574-021-00584-0. Epub 2021 Nov 23. PMID: 34815553; PMCID: PMC9012520.
105. Upadhyaya V, Choudur HN. Update on sports imaging. J Clin Orthop Trauma. 2021 Aug 8;21:101555. doi: 10.1016/j.jcot.2021.101555. PMID: 34458092; PMCID: PMC8379491.
©
WWW.SEMIOSICA.COM
VISITA IL NOSTRO BLOG
Una medicina dedicata alla prevenzione delle malattie
Alessandro Baglione
25-10-2024 10:53
25-10-2024 10:53
Medicina e intelligenza artificiale non vanno proprio così d'accordo
Alessandro Baglione
12-02-2025 19:34
12-02-2025 19:34
L'intelligenza artificiale sostituirà la medicina banale
Alessandro Baglione
07-10-2024 15:45
07-10-2024 15:45
La significazione medica dedicata alla radiologia
Alessandro Baglione
02-09-2024 00:00
02-09-2024 00:00
Possiamo avere delle diagnosi e delle cure migliori
Alessandro Baglione
22-07-2024 00:10
22-07-2024 00:10
La medicina e le scienze "dure"
Alessandro Baglione
27-06-2024 18:52
27-06-2024 18:52
La medicina e le scienze culturali
Alessandro Baglione
27-06-2024 18:51
27-06-2024 18:51
La medicina e la scienza semiotica
Alessandro Baglione
27-06-2024 18:51
27-06-2024 18:51
Una tecnologia per le decisioni mediche
Alessandro Baglione
27-06-2024 18:50
27-06-2024 18:50
I "superpoteri" della radiologia
Alessandro Baglione
03-06-2024 14:36
03-06-2024 14:36
A chi siamo di aiuto con il nostro lavoro
Alessandro Baglione
03-06-2024 13:12
03-06-2024 13:12
Le malattie associate alla gravidanza
Alessandro Baglione
30-05-2024 23:42
30-05-2024 23:42
Non è vero che lo sport fa bene
Alessandro Baglione
30-05-2024 23:32
30-05-2024 23:32
È difficile prevenire le malattie
Alessandro Baglione
30-05-2024 23:23
30-05-2024 23:23
Ah! Le malattie muscoloscheletriche...
Alessandro Baglione
30-05-2024 23:12
30-05-2024 23:12
La tollerabilità delle cure oncologiche
Alessandro Baglione
30-05-2024 23:03
30-05-2024 23:03
La riabilitazione neuromotoria è difficile
Alessandro Baglione
30-05-2024 22:52
30-05-2024 22:52
Lo "stallo" delle applicazioni software nella medicina
Alessandro Baglione
01-04-2024 18:52
01-04-2024 18:52
Il problema del cancro alla prostata
Alessandro Baglione
10-03-2024 23:00
10-03-2024 23:00
Le malattie pelviche delle donne
Alessandro Baglione
26-02-2024 23:00
26-02-2024 23:00
NOVITÀ ED EVENTI
CONTATTACI
Iscriviti alle newsletter
Scrivici una e-mail